Amgen Inc. buy BMO Capital Markets
Start price
19.12.23
/
50%
€253.60
Target price
19.12.24
€297.31
Performance (%)
-1.16%
End price
20.12.24
€250.65
Summary
This prediction ended on 20.12.24 with a price of €250.65. With a performance of -1.16%, the BUY prediction for Amgen Inc. by BMO_Capital_Markets closed slightly in the red. BMO_Capital_Markets has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. A total of €8.32 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -1.409% | -1.409% | 17.989% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $326.00 price target on the stock, up previously from $286.00.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten